BioMed Central | Articles which cite: PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease.

Log on / register
Feedback | Support | My details

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease.
Johansson M, Arlestig L, Hallmans G, Rantapää-Dahlqvist S
Arthritis Res Ther 2006, 8:R19
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]

printer friendly

to [Help]

BioMed Central articles that cite the above article:

1.

Review

Recent developments in the immunobiology of rheumatoid arthritis
Andersson AK, Li C, Brennan FM
Arthritis Research & Therapy 2008, 10:204 (14 March 2008)
[Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 4 articles in PubMed Central

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.